Forte Biosciences (NASDAQ: FBRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Forte Biosciences (NASDAQ: FBRX) through any online brokerage.
The latest price target for Forte Biosciences (NASDAQ: FBRX) was reported by Chardan Capital on Monday, September 20, 2021. The analyst firm set a price target for 3.50 expecting FBRX to rise to within 12 months (a possible 169.23% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Forte Biosciences (NASDAQ: FBRX) is $1.3 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Forte Biosciences.
Forte Biosciences’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Forte Biosciences.
Forte Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.